Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exercise
Katherine C Horton1,2, Alvaro Schwalb1,2,3, Martin J Harker1,2,4
1TB Modelling Group, TB Centre, LSHTM, London, UK.
Targeted tuberculosis (TB) interventions like community screening and vaccination show significant population impact and cost-effectiveness. Expanding efforts beyond clinic-based care is crucial for TB control, requiring policy and funding shifts.
Area of Science:
- Global Health
- Epidemiology
- Health Economics
Background:
- Tuberculosis (TB) interventions vary widely in impact and cost-effectiveness.
- Comparisons are often lacking, especially across diverse epidemiological settings.
- Understanding population-level effects and economic viability is critical for TB control.
Purpose of the Study:
- To compare the population impact and cost-effectiveness of various TB interventions.
- To evaluate interventions in Brazil, India, and South Africa, countries with different TB burdens.
- To inform policy and funding for effective TB control strategies.
Main Methods:
- A deterministic TB model was calibrated to epidemiological data from Brazil, India, and South Africa.
- Seven interventions (prevention, screening, treatment, prison screening, nutritional supplementation) were modeled.
- Standardized scale-up, coverage (80%), and efficacy data were used to estimate impact and ICERs by 2050.
Main Results:
- Vaccination, community-wide screening, and prison screening showed the greatest impact (>10% of incident TB episodes averted).
- Shortened drug-resistant TB treatment was cost-saving; prison screening in Brazil and nutritional supplementation in India had low ICERs.
- Community-wide screening and TB vaccine campaigns were more cost-effective than TB preventive treatment within countries.
Conclusions:
- High-impact TB interventions can be cost-effective.
- Effective strategies require targeting populations beyond traditional healthcare settings.
- A shift in funding, policy, and product development is necessary to realize TB control potential.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Therapeutic Drug Monitoring: Affecting Factors

